The products on this page are only available in the United States. Expedio™ Cancer Screening, $225 Determine if you carry BRCA1 and BRCA2 gene mutations, which are strong risk indicators for breast and ovarian cancer. Together, according to the CDC, BRCA1 and BRCA2 mutations account for 20% to 25% of hereditary breast cancers. The Kailos test will also test for changes in 31 additional genes, including APC, ATM, BARD1, BMPR1A, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, FLCN, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, NF1, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, RINT1, SDHB, SMAD4, STK11, TP53, VHL, and XRCC2, to inform you about risks associated with breast, ovarian, colon, and endometrial (uterine) cancers. - + Add To Cart - OR - If you live in North Alabama See if you qualify for FREE or discounted testing!